In a seismic shift for the American healthcare industry, the Fifth Circuit Court of Appeals has delivered a landmark ruling that strikes at the heart of the "Qualifying Payment Amount" (QPA)—the controversial benchmark used to settle surprise medical billing disputes. This decision represents a significant victory for healthcare providers and a stinging rebuke to federal regulators and health insurance payers, potentially altering the flow of billions of dollars in the U.S. healthcare economy.
The ruling, issued this past Tuesday, effectively invalidates key components of the methodology used by the Departments of Health and Human Services (HHS), Labor, and Treasury to calculate the QPA under the federal No Surprises Act (NSA). By siding with the Texas Medical Association (TMA) in its long-standing legal crusade, the court has signaled that the current framework for curbing surprise billing has unfairly tilted the playing field in favor of insurance companies.
The Core Conflict: Why the QPA Matters
At the heart of this legal battle is the definition of a "fair" price. The No Surprises Act was enacted in 2022 to protect patients from receiving exorbitant bills when they inadvertently receive care from out-of-network providers. To resolve payment disputes between insurers and providers, the law established an Independent Dispute Resolution (IDR) process.
The QPA is the linchpin of this process. It is intended to represent the median in-network rate that a health plan would pay for a specific service in a specific geographic area. Because arbitrators are instructed to give the QPA significant weight when deciding final payment amounts, the way it is calculated determines the bottom line for both providers and payers. If the QPA is artificially low, insurers save money, but providers argue their practice viability is threatened. If the QPA is high, insurers face increased costs, which are typically passed on to employers and patients through higher premiums.
Chronology of a Regulatory Tug-of-War
The litigation surrounding the No Surprises Act has been nothing short of relentless since its inception. To understand the gravity of the Fifth Circuit’s recent decision, one must look at the timeline of the conflict:
- January 2022: The No Surprises Act officially takes effect, aiming to eliminate balance billing for patients. However, immediate friction arises regarding the implementation of the IDR process.
- February 2022: The Texas Medical Association (TMA) secures its first major victory when a federal judge strikes down portions of the initial federal guidance, which had forced arbitrators to prioritize the QPA above all other factors.
- 2022–2023: A series of regulatory "re-writes" follow. HHS and its sister agencies attempt to refine the QPA methodology, while the TMA continues to challenge the inclusion of certain data points, arguing they suppress market rates.
- August 2023: Following a string of court losses, federal agencies scramble to adjust their guidance, leading to a state of regulatory flux that leaves healthcare systems and insurance plans in limbo.
- March 2026: The Fifth Circuit Court of Appeals issues the current ruling, declaring that the exclusion of incentive payments and the inclusion of "ghost rates" in the QPA calculation violates the original intent of the statute.
Supporting Data: "Ghost Rates" and Hidden Pay
The crux of the provider argument—and the point that ultimately swayed the Fifth Circuit—centers on two specific data points: "ghost rates" and incentive compensation.
The Problem with Ghost Rates
The Texas Medical Association argued that insurers were "gaming the system" by including contracted rates for services that providers never actually intended to deliver. These are often referred to as "ghost rates"—placeholder contracts that exist on paper but have no basis in real-world clinical practice. Because these rates are often set at artificially low levels to satisfy administrative requirements, their inclusion in the median calculation drags the total QPA downward. The court agreed with the TMA, ruling that these phantom figures have no place in a calculation intended to reflect actual market conditions.
The Exclusion of Bonuses
Furthermore, the court took issue with the exclusion of bonus and incentive payments from the QPA. In modern value-based care models, a significant portion of a physician’s compensation is tied to quality metrics, patient outcomes, and efficiency bonuses. By excluding these payments from the QPA, regulators were effectively ignoring a large chunk of the actual remuneration providers receive for their services. The court’s mandate that these payments must now be included is expected to drive the QPA—and consequently, arbitration outcomes—significantly higher.
Official Responses: A Clash of Perspectives
The reaction to the ruling has been predictably polarized, reflecting the deep divide between the healthcare provider lobby and the insurance industry.
The Provider Perspective:
Texas Medical Association President Bradford Holland praised the decision as a vindication of the medical community’s right to fair compensation. "TMA has repeatedly urged the federal government to implement the NSA in a manner that is lawful and preserves patient access and physician practice viability," Holland stated. "The appellate court’s decision is another step in the right direction for both patients and the physicians who care for them."
The Regulatory Stance:
The Departments of Health and Human Services, Labor, and Treasury remain in a difficult position. Having seen their methodology struck down multiple times, they are now tasked with the complex job of creating a new formula that satisfies the courts while preventing a surge in healthcare spending. While no formal response has been issued detailing the timeline for the new methodology, sources close to the department suggest a period of intense internal review.
The Payer Stance:
Insurance industry representatives have expressed concern that the ruling will inadvertently increase the cost of care. By forcing higher arbitration outcomes, they argue, the ruling creates a "floor" that will push up premiums for employers and consumers. They have long maintained that the QPA should be a conservative benchmark to ensure that the No Surprises Act does not become an inflationary force in the economy.
Implications: What Comes Next for Healthcare Finance?
While the Fifth Circuit’s ruling is a victory for providers, it creates a period of significant uncertainty for the entire healthcare ecosystem.
1. A Period of "Wait and See"
Because the court did not order an immediate halt to the current QPA process, the existing formula remains in place while the government drafts a replacement. This creates a "limbo" state where providers and payers must continue to navigate the IDR process under rules that have been declared legally flawed, but not yet replaced.
2. Upward Pressure on Costs
Industry analysts predict that once the new methodology is implemented—incorporating incentive bonuses and stripping out ghost rates—the average QPA will rise. For providers, this means higher revenue per out-of-network claim. For insurers, it suggests higher medical loss ratios and the potential for a renewed push for higher premiums during the next open enrollment cycle.
3. Continued Litigation
Legal experts warn that this is unlikely to be the final word. The complexity of defining "market rates" in a diverse, regionalized healthcare system means that any new methodology proposed by the federal government will likely be subjected to another round of lawsuits. The No Surprises Act has effectively turned the federal judiciary into the primary architect of healthcare billing policy, a role for which it is arguably ill-equipped.
4. The Impact on Practice Viability
For small, independent practices, the ruling is a lifeline. Many of these practices have struggled under the weight of the original QPA calculations, which they argued were designed to benefit large, deep-pocketed insurance conglomerates. By ensuring that their actual compensation—including performance incentives—is reflected in the arbitration process, smaller practices may find more stability in an increasingly consolidated market.
Conclusion: The Road Ahead
The Fifth Circuit’s decision is a profound reminder that the implementation of complex federal legislation is rarely a linear process. As the government prepares to rework the QPA formula yet again, the healthcare industry remains caught in a tug-of-war between the need for affordable care and the requirement for fair, market-based reimbursement.
While the legal battle over the No Surprises Act continues, one thing remains clear: the methodology used to calculate the value of medical services is no longer just an administrative detail—it is the central battlefield upon which the future of American healthcare finance is being decided. Both providers and payers must now prepare for a future where the benchmarks of the past are no longer reliable, and where the next iteration of the QPA will likely define the financial success—or failure—of practices and plans across the nation.
